Search
Developing an eye drop to treat dry age-related macular degeneration (AMD)
Dr Lisa Hill, University of Birmingham - £244,249
This project aims to develop a novel therapy for dry aged-related macular degeneration (AMD), delivered via an eye drop, which could reduce inflammation and restore cell health. The eye drop will include the recipe to make an important protein, known to be reduced in those with AMD.
How eye adaptation to darkness could lead to quicker AMD treatments
Dr Alison Binns, City, University of London- £233,862
Understanding why our eyes adapt differently to the dark may pave the way for quicker AMD treatments
Uncovering early changes in the eye during AMD
Dr Richard Unwin, The University of Manchester- £249,679
What’s the problem?
A person’s genes play a strong role in defining their lifetime risk of age-related macular degeneration (AMD). This project aims to identify and record differences in the structure of the eye, based on whether they have a high or low genetic risk of developing AMD.